Bridging the innovation gap for neglected tropical diseases in México: capacity building for the development of a new generation of antipoverty vaccines

the neglected tropical diseases (ntds) represent a group of chronic parasitic and related infections that promote poverty because of their impact on child development, pregnancy, and worker productivity. the estimated 20 million mexicans who live below the poverty line suffer disproportionately from a high prevalence of neglected tropical diseases such as amebiasis, chagas disease, dengue, leishmaniasis, soil-transmitted helminth infections, trachoma, and vivax malaria. however, because the ntds occur predominantly among the poor, new industrial and financial models are required to establish innovative technologies to address these conditions in mexico and elsewhere in latin america. in response, the slim initiative for antipoverty vaccine development was established to foster a public/private partnership between key academic, government, and industrial institutions in the u.s. and mexico. initial emphasis will be placed on developing new vaccines for chagas disease and leishmaniasis, two of the highest burden ntds in mexico and mesoamerica.